首页 | 本学科首页   官方微博 | 高级检索  
检索        

榄香烯注射液联合化疗与靶向药物对晚期非小细胞肺癌患者生活质量、免疫功能的影响
引用本文:范彦博,汪睿.榄香烯注射液联合化疗与靶向药物对晚期非小细胞肺癌患者生活质量、免疫功能的影响[J].世界中西医结合杂志,2021(1):119-122,127.
作者姓名:范彦博  汪睿
作者单位:安徽省胸科医院肿瘤科
摘    要:目的 探究榄香烯注射液联合化疗与靶向药物对晚期非小细胞肺癌患者的治疗效果,并分析其对患者的生活质量及免疫功能产生的影响.方法 选取2013年4月—2018年12月期间安徽省胸科医院肿瘤科收治的72例晚期非小细胞肺癌患者纳入研究,采用随机数字表法分为对照组与治疗组各36例.对照组采取常规化疗+靶向药物治疗,治疗组在此基础...

关 键 词:榄香烯注射液  化疗  靶向药物  晚期非小细胞肺癌

Effects of Elemene Injection Combined with Chemotherapy and Targeted Drugs on the Quality of Life and Immune Function in Patients with Advanced Non-Small Cell Lung Cancer
FAN Yan-bo,WANG Rui.Effects of Elemene Injection Combined with Chemotherapy and Targeted Drugs on the Quality of Life and Immune Function in Patients with Advanced Non-Small Cell Lung Cancer[J].World Journal Of Integrated Traditional and Wesrern Medicine,2021(1):119-122,127.
Authors:FAN Yan-bo  WANG Rui
Institution:(Department of Oncology,Anhui Chest Hospital,Hefei Anhui 230022)
Abstract:Objective To explore the therapeutic effect of elemene injection combined with chemotherapy and targeted drugs on patients with advanced non-small cell lung cancer,and to analyze the impact of elemene injection on the quality of life and immune function of patients.Methods From April 2013 to December 2018,72 patients with advanced non-small cell lung cancer admitted to the Department of Oncology,Anhui Chest Hospital were enrolled in the study.They wererandomly divided into control group and observation group with 36 cases in each group.The control group was treated with conventional chemotherapy and targeted drugs,and the observation group was treated with elemene injection on this basis.The clinical efficacy,expected survival time,adverse symptoms and immunity of the two groups were evaluated.The disease function and quality of life were analyzed.Results The clinical efficacy of the treatment group was significantly better than that of the control group(P<0.05).The objective response rate(ORR)(77.78%)of the treatment group was higher than that of the control group(52.78%);the expected survival time of the treatment group exceeded 12 Month accounted for 80.55%,more than 24 months accounted for 47.22%,which was significantly higher than the control group(58.33%and 22.22%)(P<0.05);the incidence of bone marrow suppression and nausea and vomiting in the treatment group was significantly lower than that in the control group(P<0.05);After treatment,the levels of CD3,CD4,and CD4/CD8 in the treatment group were significantly higher than those in the control group,and the CD8 levels were significantly lower than those in the control group(P<0.05);the Lung Cancer Symptom Scale(LCSS)of the treatment group was different The item scores were significantly lower than the control group(P<0.05).Conclusion Elemene injection combined with chemotherapy and targeted drugs has a definite effect on advanced non-small cell lung cancer patients.It can effectively improve the ORR of patients,prolong the survival period of patients,increase the immune function of patients,and improve the quality of life of patients.
Keywords:Elemene Injection  Chemotherapy  Targeted Drugs  Non-Small Cell Lung Cancer
本文献已被 CNKI 维普 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号